Literature DB >> 6078027

What happens to the psychiatric office patient treated with drugs? A follow-up study.

P Lowinger, S Dobie, S Reid.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6078027     DOI: 10.1007/bf01562615

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


× No keyword cloud information.
  11 in total

1.  Evaluation of mephenoxalone in a single- and double-blind design.

Authors:  P LOWINGER
Journal:  Am J Psychiatry       Date:  1963-07       Impact factor: 18.112

2.  Clinical evaluation of trimeglamide in anxiety.

Authors:  R A BRAUN; P LOWINGER
Journal:  Am J Psychiatry       Date:  1959-08       Impact factor: 18.112

3.  Methylnonyl dioxolane: a clinical trial.

Authors:  C SCHORER; P LOWINGER
Journal:  Am J Psychiatry       Date:  1959-10       Impact factor: 18.112

4.  The powerful placebo.

Authors:  H K BEECHER
Journal:  J Am Med Assoc       Date:  1955-12-24

5.  Evaluation of results of psychotherapy.

Authors:  M ROSENBAUM; J FRIEDLANDER; S M KAPLAN
Journal:  Psychosom Med       Date:  1956 Mar-Apr       Impact factor: 4.312

6.  A biometric evaluation of the somatotherapies in schizophrenia.

Authors:  V M STAUDT; J ZUBIN
Journal:  Psychol Bull       Date:  1957-05       Impact factor: 17.737

7.  Follow-up results in psychiatric illness.

Authors:  D W HASTINGS
Journal:  Am J Psychiatry       Date:  1958-06       Impact factor: 18.112

8.  Long term psychotherapy.

Authors:  K E APPEL; W T LHAMON; J M MYERS; W A HARVEY
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1953

9.  Manic-depressive psychosis; course when treated and untreated with electric shock.

Authors:  P E HUSTON; L M LOCHER
Journal:  Arch Neurol Psychiatry       Date:  1948-07

10.  Evaluation of psychotherapy, with a follow-up study of 62 cases of anxiety neurosis.

Authors:  H H W MILES; E L BARRABEE; J E FINESINGER
Journal:  Psychosom Med       Date:  1951 Mar-Apr       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.